Last Updated: June 24, 2026

Suppliers and packagers for AZASITE


✉ Email this page to a colleague

« Back to Dashboard


AZASITE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Thea Pharma AZASITE azithromycin SOLUTION/DROPS;OPHTHALMIC 050810 NDA Thea Pharma Inc. 82584-307-02 1 BOTTLE, DROPPER in 1 CARTON (82584-307-02) / 2.5 mL in 1 BOTTLE, DROPPER 2022-11-01
Thea Pharma AZASITE azithromycin SOLUTION/DROPS;OPHTHALMIC 050810 NDA Thea Pharma Inc. 82584-307-03 1 BOTTLE, DROPPER in 1 CARTON (82584-307-03) / 2.5 mL in 1 BOTTLE, DROPPER 2022-11-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for AZASITE

Last updated: May 29, 2026

If you mean the drug “Azasite” (brand name commonly used for topical azithromycin ophthalmic products), there is not enough reliable, source-cited information in this context to identify specific named suppliers (API manufacturers, contract manufacturers, or finished-dose packaging sites) for that product.

What patents protect azasite?
What is Azasite’s Orange Book status?
When does Azasite lose exclusivity?
What generic entry risks exist for Azasite?
What formulations are protected by Azasite patents?
What patent litigation affects Azasite?
What FDA regulatory pathway applies to Azasite generics?
Which companies are challenging Azasite with Paragraph IV?
How strong is the patent estate for Azasite?
How does Azasite compare with competing azithromycin eye drops?
Key Takeaways
No defensible supplier list can be produced from the information provided.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.